These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27989428)

  • 21. Targeted Therapies in Older Adults With Breast Cancer: What Do We Know?
    Strulov Shachar S; Hurria A; Muss HB
    J Clin Oncol; 2016 Oct; 34(28):3486-8. PubMed ID: 27432932
    [No Abstract]   [Full Text] [Related]  

  • 22. Herceptin in early breast cancer: a call for judicious use.
    Thorat MA
    Natl Med J India; 2005; 18(6):315-7. PubMed ID: 16483033
    [No Abstract]   [Full Text] [Related]  

  • 23. [21st annual San Antonio Breast Cancer Symposium. 12-15 December 1998, San Antonio, Texas].
    Tuveri G
    Clin Ter; 1999; 150(1):7-10. PubMed ID: 10367538
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature.
    Martínez MT; Pérez-Fidalgo JA; Martín-Martorell P; Cejalvo JM; Pons V; Bermejo B; Martín M; Albanell J; Lluch A
    Crit Rev Oncol Hematol; 2016 Jan; 97():96-106. PubMed ID: 26318092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highlights of the San Antonio Breast Cancer Symposium 2015: part 1.
    Benson JR; Jatoi I
    Future Oncol; 2016 Apr; 12(7):893-6. PubMed ID: 26880387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials.
    Baselga J
    Oncology; 2001; 61 Suppl 2():14-21. PubMed ID: 11694783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2012 San Antonio Breast Cancer Symposium.
    Brierley R
    Lancet Oncol; 2013 Jan; 14(1):20. PubMed ID: 23401868
    [No Abstract]   [Full Text] [Related]  

  • 28. [ASCO 2006 Gastrointestinal Cancers Symposium, San Francisco, 26-28 January 2006].
    Tumori; 2006; 92(2):1-20. PubMed ID: 16724704
    [No Abstract]   [Full Text] [Related]  

  • 29. PI3K Inhibitor Improves PFS in BELLE-2 Trial.
    Cancer Discov; 2016 Feb; 6(2):115-6. PubMed ID: 26681740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 36th San Antonio Breast Cancer Symposium: focus on clinical trial results.
    Jacot W
    Future Oncol; 2014 Mar; 10(4):511-3. PubMed ID: 24754580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Agent Abemaciclib Active in Breast Cancer.
    Cancer Discov; 2016 Aug; 6(8):809-10. PubMed ID: 27354271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple rules can improve prognostic accuracy.
    Schapira L
    J Clin Oncol; 2011 Feb; 29(4):347-9. PubMed ID: 21189394
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of pertuzumab for the treatment of HER2-positive metastatic breast cancer.
    De Mattos-Arruda L; Cortes J
    Adv Ther; 2013 Jul; 30(7):645-58. PubMed ID: 23881722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Doubling time of progression-free survival by palbociclib in metastatic breast cancer].
    L'Allemain G
    Bull Cancer; 2015 Apr; 102(4):300. PubMed ID: 26042255
    [No Abstract]   [Full Text] [Related]  

  • 35. Trastuzumab for early breast cancer.
    Bryant J; Geyer CE
    Lancet; 2006 Mar; 367(9512):728. PubMed ID: 16517268
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adjuvant therapy with trastuzumab (Herceptin) in primary breast cancer].
    Huober J; Jackisch C; Untch M; Möbus V; Wallwiener D; Kaufmann M; Minkwitz G
    Zentralbl Gynakol; 2006 Feb; 128(1):30-7. PubMed ID: 16450285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER2/neu in systemic therapy for women with breast cancer: a systematic review.
    Dhesy-Thind B; Pritchard KI; Messersmith H; O'Malley F; Elavathil L; Trudeau M
    Breast Cancer Res Treat; 2008 May; 109(2):209-29. PubMed ID: 17636396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant! When the new world meets the old world.
    Huober J; Thürlimann B
    Lancet Oncol; 2009 Nov; 10(11):1028-9. PubMed ID: 19880058
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of Herceptin in primary breast cancer: views from North America and Europe.
    Leyland-Jones B; Smith I
    Oncology; 2001; 61 Suppl 2():83-91. PubMed ID: 11694792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. San Antonio Breast Cancer Symposium 2019.
    Gourd K
    Lancet Oncol; 2020 Jan; 21(1):28. PubMed ID: 31866168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.